Nectin Therapeutics
Biotech company developing next-generation immunotherapy agents to unlock the immune system.
About
Technology stack
detected 2026-06-12No comments yet. Be the first to share your take.
What does Nectin Therapeutics do?
Nectin Therapeutics is a biotechnology company focused on harnessing the power of the immune system. They are developing a portfolio of advanced immunotherapy agents designed to overcome the limitations of existing treatments, aiming to improve outcomes for patients who do not respond to current therapies or experience relapse.
How much funding has Nectin Therapeutics raised?
Nectin Therapeutics has raised a total of $64M in funding. The most recent round on record is Series C.
When was Nectin Therapeutics founded?
Nectin Therapeutics was founded in 2016.
What industry does Nectin Therapeutics operate in?
Nectin Therapeutics operates in Life Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody.
How many employees does Nectin Therapeutics have?
Nectin Therapeutics has approximately 11 people on record.